|
Report Date : |
05.12.2013 |
IDENTIFICATION DETAILS
|
Name : |
AMIPHARMA LABORATORIES LTD |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
01.04.1981 |
|
|
|
|
Com. Reg. No.: |
S2185, |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturers of pharmaceuticals and drugs. |
|
|
|
|
No. of Employees : |
550 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Sudan |
C1 |
C1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SUDAN - ECONOMIC OVERVIEW
Sudan is an extremely poor country that has had to deal with
social conflict, civil war, and the July 2011 secession of South Sudan - the
region of the country that had been responsible for about three-fourths of the
former Sudan's total oil production. The oil sector had driven much of Sudan's
GDP growth since it began exporting oil in 1999. For nearly a decade, the
economy boomed on the back of increases in oil production, high oil prices, and
significant inflows of foreign direct investment. Following South Sudan''s
secession, Sudan has struggled to maintain economic stability, because oil
earnings now provide a far lower share of the country''s need for hard currency
and for budget revenues. Sudan is attempting to generate new sources of
revenues, such as from gold mining, while carrying out an austerity program to
reduce expenditures. Agricultural production continues to employ 80% of the
work force. Sudan introduced a new currency, still called the Sudanese pound,
following South Sudan''s secession, but the value of the currency has fallen
since its introduction. Khartoum formally devalued the currency in June 2012,
when it passed austerity measures that included gradually repealing fuel
subsidies. Sudan also faces rising inflation, which reached 47% on an annual
basis in November 2012. Ongoing conflicts in Southern Kordofan, Darfur, and the
Blue Nile states, lack of basic infrastructure in large areas, and reliance by
much of the population on subsistence agriculture ensure that much of the
population will remain at or below the poverty line for years to come
Source
: CIA
Company Name : AMIPHARMA LABORATORIES LTD
Country of Origin : Sudan
Legal Form : Limited Liability Company
Registration Date : 1st April 1981
Commercial Registration Number : S2185, Khartoum
Issued Capital : SD 75,000,000
Paid up Capital : SD 75,000,000
Total Workforce : 550
Activities : Manufacturers of pharmaceuticals and drugs.
Financial Condition : Good
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Person Interviewed : Elhadi Mohammed Ibrahim, Finance Manager
AMIPHARMA LABORATORIES LTD
Location : Khartoum
North Industrial Area, Plot No. 33, Block 7
PO Box : 180
Town : Khartoum
North 13311
Country : Sudan
Telephone : (249-185)
311442 / 311443 / 311448 / 311449
Facsimile : (249-185)
314721 / 314722
Email : amipharma_sudan@yahoo.com
/ info@amipharma-labs.com / elhadiibrahim55@gmail.com
Subject operates from a suite of offices and a factory covering an area
of 13,500 square metres that are owned and located in the Industrial Area of
Khartoum North.
Name Position
·
Dr Ahmed Al Badawi Mohamed Al Ameen Hamid Managing Director
·
Al Rasheed Mohamed Al Ameen Hamid Director
·
Mahmoud Mohamed Al Ameen Hamid Director
·
Samia Ali Hamad Administration
Manager
·
Luba Al Taher Marketing Manager
·
Faisal Sabir Suliman Production
Manager
·
Mamoun Al Taher Quality
Assurance Manager
·
Nassereddine Mohamed Quality
Control Manager
·
Elhadi Mohammed Ibrahim Finance
Manager
·
Jahindra Kumar Sales
Manager
·
Asim Sirelkhatim Ali Human
Resources Manager
·
Elamin Ahmed Elebedawi M
Elamin Planning
Manager
Date of
Establishment : 1st
April 1981
Legal Form : Limited Liability
Company
Commercial Reg. No. :
S2185,
Khartoum
Issued Capital : SD 75,000,000
Paid up Capital : SD 75,000,000
·
Dr Ahmed Al Badawi Mohamed Al Ameen Hamid
·
Al Rasheed Mohamed Al Ameen Hamid
·
Mahmoud Mohamed Al Ameen Hamid
· Modern
Refrigeration Factory (Liebherr)
Khartoum
· ARM Trading &
Engineering
Khartoum
Activities: Engaged in the manufacture and preparation of pharmaceuticals and
drugs, as well as antibiotic capsules,
dry powders, syrups and suspensions.
Production
Capacities:
· Plain tablets 450 million
· Coated tablets 250 million
· Capsules 180 million
· Dry powders 6 million
· Syrups and
suspensions 8 million
Import Countries: Europe and GCC countries.
Brand Names: AMIPHARMA
Operating Trend: Steady
Subject has a workforce of approximately 550 employees.
Financial highlights provided by local sources are given below:
Currency: Sudanese Dinars (SD)
Year
Ending 31/12/11: Year
Ending 31/12/12:
Total Sales SD
992,000,000 SD 1,000,000,000
Local sources consider subject’s financial condition to be Good.
The above figures were provided by Mr Elhadi Mohammed Ibrahim, Finance Manager
·
Al Shamal Islamic Bank
Sayed Abdul Rahman
Avenue
Khartoum
No complaints regarding subject’s payments have been reported.
Credit amount 100,000
Amount overdue 0
Payment terms 90
days
Payment Method Letters
of Credit
Paying record No
Complaints
Currency US
Dollars
Established in 1982, subject is involved in the manufacture and
preparation of pharmaceuticals and drugs under the brand name Amipharma.
According to local sources, subject’s financial condition is
satisfactory whilst payments are made in a timely manner. The company’s
operating history is reportedly clear and the company is considered to be a
fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.33 |
|
|
1 |
Rs.102.18 |
|
Euro |
1 |
Rs.84.68 |
INFORMATION DETAILS
|
Report
Prepared by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.